Novavax
Healthcare
FDA Panel Backs New COVID Vaccines for JN.1 Variant by Fall
An expert panel from the Food and Drug Administration (FDA) voted unanimously on Wednesday to develop new COVID-19 vaccines specifically targeting the JN.1...
Business
Novavax Shares Soar 130% on $1.4B Sanofi Deal
Novavax, a biotechnology company, experienced a staggering surge in its stock price, soaring over 130% in Friday’s early trading hours. This remarkable increase...
